A systematic review of rapid drug susceptibility tests for multidrug-resistant tuberculosis using rifampin resistance as a surrogate

Expert Opinion on Medical Diagnostics

Volumn 3, Issue 2, 2009, Pages 99-122

  Chang, Kwok Chiu ^a   Yew, Wing Wai ^b   Zhang, Ying ^c  

^a Wanchai Chest Clinic   (Hong Kong)

^b GRANTHAM HOSPITAL   (Hong Kong)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Meta analysis; Multidrug resistant; Rifampin; Susceptibility; Tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; DNA; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; NITRATE REDUCTASE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GROWTH; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; DIAGNOSTIC ACCURACY; DISEASE MARKER; DNA SEQUENCE; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; DRUG TARGETING; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDLINE; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM; SPUTUM SMEAR; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 70249108290     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530050802665694     Document Type: Review

References (258)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2008.393. Geneva, Switzerland: WHO, 2008
2. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. Third edition. WHO/CDS/TB/2003.313. Geneva, Switzerland: WHO, 2003
3. World Health Organization. Anti-tuberculosis drug resistance in the world. Fourth global report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008
4. Yew WW, Leung CC. Management of multidrug-resistant tuberculosis: Update 2007. Respirology 2008;13:21-46 • Overview of management of multidrug-resistant tuberculosis.
5. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-305
6. Espinal MA, Laserson K, Camacho M, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001;5:887-893 (Pubitemid 32976631)
7. Zhang Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci 2004;9:1136-1156 (Pubitemid 39060834)
8. Zhang Y. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 2005;45:529-564 (Pubitemid 40261816)
9. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969;41:21-43
10. Park MM, Davis AL, Schluger NW, et al. Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. Am J Respir Crit Care Med 1996;153:317-324
11. Caminero JA. World Health Organization, American Thoracic Society, British Thoracic Society. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006;10:829-37 • Overview of evidence and controversies in treatment of multidrug-resistant tuberculosis.
12. Hong Kong Chest Service/British Medical Research Council. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1987;136:1339-1342
13. Mphahlele M, Syre H, Valvatne H, et al. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol 2008;46:3459-3464
14. Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986;133:423-430 (Pubitemid 16126276)
15. Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998;36:1969-1973 (Pubitemid 28277786)
16. Telenti A, Imboden P, Marchesi F, et al. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob Agents Chemother 1993;37:2054-2058 (Pubitemid 23298188)
17. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993;341:647-650 (Pubitemid 23083244)
18. Telenti A, Honore N, Bernasconi C, et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol 1997;35:719-723 (Pubitemid 27083868)
19. Kapur V, Li LL, Iordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994;32:1095-1098 (Pubitemid 24100101)
20. Williams DL, Waguespack C, Eisenach K, et al. Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994;38:2380-2386
21. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995;8:496-514
22. Traore H, Fissette K, Bastian I, et al. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 2000;4:481-484 (Pubitemid 30256852)
23. Zhang Y, Heym B, Allen B, et al. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992;358:591-593
24. Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994;263:227-230 (Pubitemid 24067929)
25. Scorpio A, Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 1996;2:662-667 (Pubitemid 26191953)
26. Telenti A, Philipp WJ, Sreevatsan S, et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 1997;3:567-570 (Pubitemid 27198658)
27. Finken M, Kirschner P, Meier A, et al. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol 1993;9:1239-1246 (Pubitemid 23286255)
28. Okamoto S, Tamaru A, Nakajima C, et al. Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol Microbiol 2007;63:1096-1106 (Pubitemid 46188264)
29. Wade MM, Zhang Y. Mechanisms of drug resistance in Mycobacterium tuberculosis. Front Biosci 2004;9:975-94 •• A comprehensive review on mechanisms of drug resistance in tuberculosis.
30. Zhang Y, Jacobs WR Jr. Mechanisms of drug action, drug resistance and drug tolerance in Mycobacterium tuberculosis: expected phenotypes from evolutionary pressures from a highly successful pathogen. In: Kaufmann SHE, Rubin E, editors. Handbook of tuberculosis. KGaA, Weinheim, Germany: Wiley-VCH Verlag GmbH & Co; 2008. vol 1 p. 323-378 •• A comprehensive review on mechanisms of drug resistance in tuberculosis.
31. Heym B, Honore N, Truffot-Pernot C, et al. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 1994;344:293-298 (Pubitemid 24230296)
32. Sekiguchi J, Nakamura T, Miyoshi-Akiyama T, et al. Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains. J Clin Microbiol 2007;45:2802-2807 (Pubitemid 47417318)
33. Zhang Y, Mitchison D. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 2003;7:6-21 • A comprehensive review on pyrazinamide and its action.
34. Troesch A, Nguyen H, Miyada CG, et al. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol 1999;37:49-55 (Pubitemid 29004179)
35. Wade MM, Volokhov D, Peredelchuk M, et al. Accurate mapping of mutations of pyrazinamide-resistant Mycobacterium tuberculosis strains with a scanning-frame oligonucleotide microarray. Diagn Microbiol Infect Dis 2004;49:89-97 (Pubitemid 38746737)
36. Brown TJ, Herrera-Leon L, Anthony RM, Drobniewski FA. The use of macroarrays for the identification of MDR Mycobacterium tuberculosis. J Microbiol Methods 2006;65:294-300
37. Shamputa IC, Rigouts And L, Portaels F. Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens. APMIS 2004;112:728-752
38. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 2006;6:423-32 • A comprehensive review on new tools for detecting drug-resistant tuberculosis.
39. Lin SG, Probert W, Lo M, Desmond E. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J Clin Microbiol 2004;42:4204-4208 (Pubitemid 39296145)
40. Raut U, Narang P, Mendiratta DK, et al. Evaluation of rapid MTT tube method for detection of drug susceptibility of Mycobacterium tuberculosis to rifampicin and isoniazid. Indian J Med Microbiol 2008;26:222-227
41. Coban AY, Cekic Cihan C, Bilgin K, et al. Rapid susceptibility test for Mycobacterium tuberculosis to isoniazid and rifampin with resazurin method in screw-cap tubes. J Chemother 2006;18:140-143 (Pubitemid 43774287)
42. Kahn A, Groswasser J, Rebuffat E, et al. Sleep and cardiorespiratory characteristics of infant victims of sudden death: a prospective case-control study. Sleep 1992;15:287-292
43. Yajko DM, Madej JJ, Lancaster MV, et al. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J Clin Microbiol 1995;33:2324-2327
44. Golyshevskaia VI, Korneev AA, Chernousova LN, et al. New microbiological Techniques in diagnosis of tuberculosis. Probl Tuberk 1996;6:22-25
45. Griess JP. Bemerkungen zu der Abhandlung der. HH: Wesely und Benedikt. Uber einige Azoverbindungen. Ber Deutsch Chem Ges 1879;12:426-428
46. Montoro E, Lemus D, Echemendia M, et al. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother 2005;55:500-505 (Pubitemid 40542590)
47. Poojary A, Nataraj G, Kanade S, et al. Rapid antibiotic susceptibility testing of Mycobacterium tuberculosis: its utility in resource poor settings. Indian J Med Microbiol 2006;24:268-272 (Pubitemid 46033978)
48. Affolabi D, Odoun M, Sanoussi N, et al. Rapid and Inexpensive Detection of Multidrug Resistant Tuberculosis with the Nitrate Reductase Assay using Liquid Medium and Applied directly to Sputum Samples. J Clin Microbiol 2008;46:3243-3245
49. Caviedes L, Lee TS, Gilman RH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 2000;38:1203-1208 (Pubitemid 30140586)
50. Moore DAJ, Evans CAW, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355:1539-50 • Field evaluation of microscopic observation drug-susceptibility assay for drug-resistant tuberculosis.
51. Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 2005;5:62 • Meta-analysis on commercial line probes for detecting rifampicin-resistant tuberculosis. (Pubitemid 41519224)
52. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008 . Published online 9 Jul 2008, doi:10.1183/09031936.00061808 • Meta-analysis on GenoType MTBDR assays for detecting multi-drug resistant tuberculosis.
53. Martin A, Portaels F, Palomino JC. Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2007;59:175-83 • Meta-analysis on colorimetric redox-indicator methods for detecting multi-drug resistant tuberculosis.
54. Martin A, Panaiotov S, Portaels F, et al. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2008;62:56-64 • Meta-analysis on nitrate reductase assays for detecting multi-drug resistant tuberculosis.
55. Pai M, Kalantri S, Pascopella L, et al. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J Infect 2005;51:175-87 • Meta-analysis on bacteriophage-based assays for detecting multi-drug resistant tuberculosis. (Pubitemid 41554824)
56. Agresti A. Analysis of ordinal categorical data. New York: John Wileys & Sons; 1984
57. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001;323:157-62 • A comprehensive review on different summary statistics for combining studies in meta analysis of diagnostic and screening tests. (Pubitemid 32678396)
58. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560 (Pubitemid 37088507)
59. Miotto P, Piana F, Cirillo DM, Migliori GB. Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2008;46:393-394
60. Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008;177:787-792
61. Ruiz M, Torres MJ, Llanos AC, et al. Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR. J Clin Microbiol 2004;42:1585-1589 (Pubitemid 38500800)
62. Albert H, Trollip AP, Seaman T, et al. Evaluation of a rapid screening test for rifampicin resistance in re-treatment tuberculosis patients in the Eastern Cape. S Afr Med J 2007;97:858-863 (Pubitemid 47542655)
63. Albert H, Trollip A, Seaman T, Mole RJ. Simple, phage-based (FASTPplaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum. Int J Tuberc Lung Dis 2004;8:1114-1119 (Pubitemid 39201258)
64. Farnia P, Masjedi MR, Mohammadi F, et al. Colorimetric detection of multidrug-resistant or extensively drug-resistant tuberculosis by use of malachite green indicator dye. J Clin Microbiol 2008;46:796-799 (Pubitemid 351231341)
65. Kim BJ, Lee KH, Park BN, et al. Detection of rifampin-resistant Mycobacterium tuberculosis in sputa by nested PCR-linked single-strand conformation polymorphism and DNA sequencing. J Clin Microbiol 2001;39:2610-2617 (Pubitemid 32606242)
66. Abate G, Aseffa A, Selassie A, et al. Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 2004;42:871-873 (Pubitemid 38222685)
67. Scarpellini P, Braglia S, Carrera P, et al. Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis. Antimicrob Agents Chemother 1999;43:2550-2554 (Pubitemid 29471246)
68. Affolabi D, Odoun M, Martin A, et al. Evaluation of direct detection of Mycobacterium tuberculosis rifampin resistance by a nitrate reductase assay applied to sputum samples in Cotonou, Benin. J Clin Microbiol 2007;45:2123-2125 (Pubitemid 47203780)
69. Solis LA, Shin SS, Han LL, et al. Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru. Int J Tuberc Lung Dis 2005;9:760-764 (Pubitemid 41139128)
70. Musa HR, Ambroggi M, Souto A, Angeby KAK. Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples. J Clin Microbiol 2005;43:3159-3161 (Pubitemid 40981317)
71. De Beenhouwer H, Lhiang Z, Jannes G, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis 1995;76:425-430
72. Johansen IS, Lundgren B, Sosnovskaja A, Thomsen VO. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol 2003;41:4454-4456 (Pubitemid 37099730)
73. Viveiros M, Leandro C, Rodrigues L, et al. Direct application of the INNO-LiPA Rif. TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J Clin Microbiol 2005;43:4880-4884 (Pubitemid 41298302)
74. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007;45:2635-2640 (Pubitemid 47295497)
75. Somoskovi A, Dormandy J, Mitsani D, et al. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol 2006;44:4459-4463 (Pubitemid 44940754)
76. Hillemann D, Rusch-Gerdes S, Richter E. Application of the Genotype MTBDR assay directly on sputum specimens. Int J Tuberc Lung Dis 2006;10:1057-1059 (Pubitemid 44378986)
77. Bang D, Bengard Andersen A, Thomsen VO. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J Clin Microbiol 2006;44:2605-2608 (Pubitemid 44092440)
78. Albert H, Heydenrych A, Brookes R, et al. Performance of a rapid phage-based test, FASTPlaqueTB, to diagnose pulmonary tuberculosis from sputum specimens in South Africa. Int J Tuberc Lung Dis 2002;6:529-537 (Pubitemid 34601871)
79. Muzaffar R, Batool S, Aziz F, et al. Evaluation of the FASTPlaqueTB assay for direct detection of Mycobacterium tuberculosis in sputum specimens. Int J Tuberc Lung Dis 2002;6:635-640 (Pubitemid 36898190)
80. Mole R, Trollip A, Abrahams C, et al. Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis. J Med Microbiol 2007;56:1334-1339 (Pubitemid 350105601)
81. World Health Organization. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): policy statement. Geneva, Switzerland: WHO, 2008
82. Grandjean L, Moore DAJ. Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis 2008;21:454-61 • Overview of recent diagnostic advances for drug-resistant tuberculosis.
83. Acuna-Villaorduna C, Vassall A, Henostroza G, et al. Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries. Clin Infect Dis 2008;47:487-95 • Cost-effectiveness analysis of a few rapid assays for detecting multi-drug resistant tuberculosis.
84. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 2002;40:4435-4438 (Pubitemid 35434927)
85. Chan RCY, Hui M, Chan EWC, et al. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2007;59:866-873 (Pubitemid 47078721)
86. World Health Organization. Anti-tuberculosis drug resistance in the world. Report No. 3. The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. WHO/HTM/TB/2004.343. Geneva, Switzerland: WHO, 2004
87. Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 2007;30:623-626 (Pubitemid 351194820)
88. Giannoni F, Iona E, Sementilli F, et al. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005;49:2928-2933 (Pubitemid 40917612)
89. Cheng AFB, Yew WW, Chan EWC, et al. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 2004;48:596-601 (Pubitemid 38141721)
90. Yew WW, Chan E, Chan CY, Cheng AF. Genotypic and phenotypic resistance of Mycobacterium tuberculosis to rifamycins and fluoroquinolones. Int J Tuberc Lung Dis 2002;6:936-937 (Pubitemid 35190710)
91. Siddiqi N, Shamim M, Hussain S, et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002;46:443-450 (Pubitemid 34087194)
92. Huang T, Kunin CM, Shin-Jung LEE, et al. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J Antimicrob Chemother 2005;56:1058-1062
93. Lee ASG, Tang LLH, Lim IHK, Wong SY. Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore. Int J Infect Dis 2002;6:48-51 (Pubitemid 34716689)
94. Zhao JR, Bai YJ, Zhang QH, et al. Pyrosequencing-based approach for rapid detection of rifampin-resistant Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2005;51:135-137 (Pubitemid 40215424)
95. Zhao J, Bai Y, Wang Y, et al. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005;9:328-332 (Pubitemid 40392951)
96. Marttila H, Makinen J, Marjamaki M, Soini H. Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. Eur J Clin Microbiol Infect Dis 2008. Published online 22 Aug 2008, doi:10.1007/s10096-008-0584-5
97. Jureen P, Engstrand L, Eriksson S, et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J Clin Microbiol 2006;44:1925-1929 (Pubitemid 43902137)
98. Arnold C, Westland L, Mowat G, et al. Single-nucleotide polymorphism-based differentiation and drug resistance detection in Mycobacterium tuberculosis from isolates or directly from sputum. Clin Microbiol Infect 2005;11:122-130 (Pubitemid 40253816)
99. Sheng J, Li J, Sheng G, et al. Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China. J Appl Microbiol 2008;105:904-911
100. Cheng X, Zhang J, Yang L, et al. A new Multi-PCR-SSCP assay for simultaneous detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis. J Microbiol Methods 2007;70:301-305 (Pubitemid 47198136)
101. Isfahani BN, Tavakoli A, Salehi M, Tazhibi M. Detection of rifampin resistance patterns in Mycobacterium tuberculosis strains isolated in Iran by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing methods. Mem Inst Oswaldo Cruz 2006;101:597-602 (Pubitemid 44555603)
102. Hofling CC, Pavan EM, Giampaglia CMS, et al. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil. Int J Tuberc Lung Dis 2005;9:87-93 (Pubitemid 40095114)
103. Mani C, Selvakumar N, Kumar V, et al. Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2003;7:652-659 (Pubitemid 36806860)
104. Kim B, Lee K, Yun Y, et al. Simultaneous identification of rifampin-resistant Mycobacterium tuberculosis and nontuberculous mycobacteria by polymerase chain reaction-single strand conformation polymorphism and sequence analysis of the RNA polymerase gene (rpoB). J Microbiol Methods 2004;58:111-118 (Pubitemid 38716135)
105. Wu X, Zhang J, Zhuang Y, et al. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates. Chin Med J (Engl) 1999;112:524-528 (Pubitemid 29283683)
106. Sharma M, Altamirano M, Prasad HK, et al. Characterization by single strand conformation polymorphism of mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis in strains from Vancouver, Mexico City and New Delhi. J Assoc Physicians India 2000;48:568-572
107. Bobadilla-Del-Valle M, Ponce-De-Leon A, Arenas-Huertero C, et al. rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. Emerg Infect Dis 2001;7:1010-1013 (Pubitemid 33115782)
108. Siddiqi N, Shamim M, Jain NK, et al. Molecular genetic analysis of multi-drug resistance in Indian isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 1998;93:589-594 (Pubitemid 128526856)
109. Lee H, Cho SN, Bang HE, et al. Molecular analysis of rifampin-resistant Mycobacterium tuberculosis isolated from Korea by polymerase chain reaction-single strand conformation polymorphism sequence analysis. Int J Tuberc Lung Dis 1998;2:585-589 (Pubitemid 28320068)
110. Cooksey R, Morlock G, Holloway B, et al. Comparison of Two Nonradioactive, Single-Strand Conformation Polymorphism Electrophoretic Methods for Identification of rpoB Mutations in Rifampin-Resistant Isolates of Mycobacterium tuberculosis. Mol Diagn 1998;3:73-79
111. Cingolani A, Antinori A, Sanguinetti M, et al. Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. J Infect Dis 1999;179:1025-1029 (Pubitemid 29159353)
112. Scarpellini P, Braglia S, Brambilla AM, et al. Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system. J Clin Microbiol 1997;35:2802-2806 (Pubitemid 27452413)
113. Kim BJ, Kim SY, Park BH, et al. Mutations in the rpoB gene of Mycobacterium tuberculosis that interfere with PCR-single-strand conformation polymorphism analysis for rifampin susceptibility testing. J Clin Microbiol 1997;35:492-494 (Pubitemid 27043932)
114. Tracevska T, Jansone I, Broka L, et al. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol 2002;40:3789-3792
115. Victor TC, Warren R, Butt JL, et al. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis. J Med Microbiol 1997;46:847-857 (Pubitemid 27417847)
116. Torres MJ, Criado A, Palomares JC, Aznar J. Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol 2000;38:3194-3199 (Pubitemid 30693903)
117. Piana A, Orru M, Masia MD, et al. Detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis strains by single-strand conformation polymorphism analysis and restriction fragment length polymorphism. New Microbiol 2003;26:375-381 (Pubitemid 40081727)
118. Gong G, Lee H, Kang GH, et al. Nested PCR for diagnosis of tuberculous lymphadenitis and PCR-SSCP for identification of rifampicin resistance in fine-needle aspirates. Diagn Cytopathol 2002;26:228-231 (Pubitemid 34273511)
119. Felmlee TA, Liu Q, Whelen AC, et al. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol 1995;33:1617-1623
120. Torres MJ, Criado A, Gonzalez N, et al. Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain. Int J Tuberc Lung Dis 2002;6:160-163 (Pubitemid 34263708)
121. Tesic J, Lepsanovic Z, Mirovic V. Evaluation of usefulness of single-strand conformation polymorphism method for rapid detection of rifampicin-resistant Mycobacterium tuberculosis. Vojnosanit Pregl 2004;61:169-172
122. Sreevatsan S, Bookout J, Ringpis F, et al. Comparative Evaluation of Cleavase Fragment Length Polymorphism With PCR-SSCP and PCR-RFLP to Detect Antimicrobial Agent Resistance in Mycobacterium tuberculosis. Mol Diagn 1998;3:81-91 (Pubitemid 28308742)
123. Pretorius GS, Sirgel FA, Schaaf HS, et al. Rifampicin resistance in Mycobacterium tuberculosis-rapid detection and implications in chemotherapy. S Afr Med J 1996;86:50-55 (Pubitemid 26058904)
124. Gonzalez N, Torres MJ, Aznar J, Palomares JC. Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. Tuberc Lung Dis 1999;79:187-190 (Pubitemid 29348509)
125. Saribas Z, Kocagoz T, Alp A, Gunalp A. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates by heteroduplex analysis and determination of rifamycin cross-resistance in rifampin-resistant isolates. J Clin Microbiol 2003;41:816-818 (Pubitemid 36184204)
126. Nachamkin I, Kang C, Weinstein MP. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis 1997;24:894-900 (Pubitemid 27193874)
127. Williams DL, Spring L, Gillis TP, et al. Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens. Clin Infect Dis 1998;26:446-450 (Pubitemid 28083961)
128. Thomas GA, Williams DL, Soper SA. Capillary electrophoresis-based heteroduplex analysis with a universal heteroduplex generator for detection of point mutations associated with rifampin resistance in tuberculosis. Clin Chem 2001;47:1195-1203 (Pubitemid 32579106)
129. Kiepiela P, Bishop K, Kormuth E, et al. Comparison of PCR-heteroduplex characterization by automated DNA sequencing and line probe assay for the detection of rifampicin resistance in Mycobacterium tuberculosis isolates from KwaZulu-Natal, South Africa. Microb Drug Resist 1998;4:263-269 (Pubitemid 29180096)
130. Mayta H, Gilman RH, Arenas F, et al. Evaluation of a PCR-based universal heteroduplex generator assay as a tool for rapid detection of multidrug-resistant Mycobacterium tuberculosis in Peru. J Clin Microbiol 2003;41:5774-5777 (Pubitemid 37543285)
131. Nash KA, Gaytan A, Inderlied CB. Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay. J Infect Dis 1997;176:533-536 (Pubitemid 27328783)
132. Mokrousov I, Filliol I, Legrand E, et al. Molecular characterization of multiple-drug-resistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene. Res Microbiol 2002;153:213-219 (Pubitemid 34327894)
133. McCammon MT, Gillette JS, Thomas DP, et al. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis. Antimicrob Agents Chemother 2005;49:2200-2209 (Pubitemid 40734446)
134. Liu YC, Huang TS, Huang WK, et al. Dideoxy fingerprinting for rapid screening of rpoB gene mutations in clinical isolates of Mycobacterium tuberculosis. J Formos Med Assoc 1998;97:400-404 (Pubitemid 28318275)
135. Cooksey RC, Holloway BP, Oldenburg MC, et al. Evaluation of the invader assay, a linear signal amplification method, for identification of mutations associated with resistance to rifampin and isoniazid in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000;44:1296-1301 (Pubitemid 30228308)
136. Brossier F, Veziris N, Truffot-Pernot C, et al. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol 2006;44:3659-3664 (Pubitemid 46768798)
137. Al-Mutairi N, Ahmad S, Mokaddas E. Performance of the genotype MTBDR assay for molecular detection of multidrug-resistant strains of Mycobacterium tuberculosis. Ann Saudi Med 2008;28:203-206
138. Miotto P, Piana F, Penati V, et al. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol 2006;44:2485-2491 (Pubitemid 44092416)
139. Makinen J, Marttila HJ, Marjamaki M, et al. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2006;44:350-352 (Pubitemid 43222221)
140. Hillemann D, Weizenegger M, Kubica T, et al. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005;43:3699-3703 (Pubitemid 41129648)
141. Cavusoglu C, Turhan A, Akinci P, Soyler I. Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006;44:2338-2342 (Pubitemid 44092395)
142. Akpaka PE, Baboolal S, Clarke D, et al. Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean. J Clin Microbiol 2008;46:3426-3428
143. Rossau R, Traore H, De Beenhouwer H, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997;41:2093-2098
144. Marttila HJ, Soini H, Vyshnevskiy BI, et al. Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis 1998;30:129-132 (Pubitemid 28389068)
145. Gamboa F, Cardona PJ, Manterola JM, et al. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis 1998;17:189-192 (Pubitemid 28306267)
146. Sintchenko V, Chew WK, Jelfs PJ, Gilbert GL. Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia. Pathology 1999;31:257-260 (Pubitemid 29417609)
147. Marttila HJ, Soini H, Vyshnevskaya E, et al. Line probe assay in the rapid detection of rifampin-resistant Mycobacterium tuberculosis directly from clinical specimens. Scand J Infect Dis 1999;31:269-273 (Pubitemid 29389235)
148. Liu YC, Huang TS, Huang WK. Line probe assay for rapid detection of mutations in the rpoB gene of Mycobacterium tuberculosis. J Formos Med Assoc 1999;98:582-585 (Pubitemid 29441313)
149. Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol 1999;37:2663-2666 (Pubitemid 29337295)
150. de Oliveira MM, da Silva Rocha A, Cardoso Oelemann M, et al. Rapid detection of resistance against rifampicin in isolates of Mycobacterium tuberculosis from Brazilian patients using a reverse-phase hybridization assay. J Microbiol Methods 2003;53:335-342 (Pubitemid 36412047)
151. Bartfai Z, Somoskovi A, Kodmon C, et al. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 2001;39:3736-3739 (Pubitemid 32954534)
152. Ahmad S, Mokaddas E, Fares E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait and Dubai. Diagn Microbiol Infect Dis 2002;44:245-252 (Pubitemid 36001980)
153. Ahmad S, Araj GF, Akbar PK, et al. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East. Diagn Microbiol Infect Dis 2000;38:227-232 (Pubitemid 32056227)
154. Somoskovi A, Song Q, Mester J, et al. Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system. J Clin Microbiol 2003;41:2822-2826 (Pubitemid 36842265)
155. Sharma M, Sethi S, Mishra B, et al. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay. Indian J Med Res 2003;117:76-80 (Pubitemid 36998665)
156. Lemus D, Martin A, Montoro E, et al. Rapid alternative methods for detection of rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2004;54:130-133 (Pubitemid 39028979)
157. Herrera L, Jimenez S, Valverde A, et al. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents 2003;21:403-408
158. Srivastava K, Das R, Jakhmola P, et al. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis. Indian J Med Res 2004;120:100-105 (Pubitemid 39248285)
159. Skenders G, Fry AM, Prokopovica I, et al. Multidrug-resistant tuberculosis detection, Latvia. Emerg Infect Dis 2005;11:1461-1463 (Pubitemid 41209148)
160. Jureen P, Werngren J, Hoffner SE. Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 2004;84:311-316 (Pubitemid 38858117)
161. Ahmad S, Mokaddas E. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int J Antimicrob Agents 2005;26:205-212 (Pubitemid 41219606)
162. Tortoli E, Marcelli F. Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility. Eur J Clin Microbiol Infect Dis 2007;26:51-55 (Pubitemid 46089582)
163. Sam I, Drobniewski F, More P, et al. Mycobacterium tuberculosis and rifampin resistance, United Kingdom. Emerg Infect Dis 2006;12:752-759
164. Ozkutuk N, Gazi H, Surucuoglu S, et al. Characterization of rpoB mutations by line probe assay in rifampicin-resistant mycobacterium tuberculosis clinical isolates from the aegean region in Turkey. Jpn J Infect Dis 2007;60:211-213 (Pubitemid 47365044)
165. Toungoussova OS, Sandven P, Mariandyshev AO, et al. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 2002;40:1930-1937 (Pubitemid 34596365)
166. Soudani A, Hadjfredj S, Zribi M, et al. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates. J Clin Microbiol 2007;45:3095-3097 (Pubitemid 47417364)
167. Negi SS, Anand R, Pasha ST, et al. Molecular characterization of mutation associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis isolates. Indian J Exp Biol 2006;44:547-553 (Pubitemid 44049406)
168. March F, Garriga X, Rodriguez P, et al. Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis. Clin Infect Dis 1997;25:1044-1047 (Pubitemid 27513183)
169. Cooksey RC, Morlock GP, Glickman S, Crawford JT. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 1997;35:1281-1283 (Pubitemid 27175271)
170. Cirillo DM, Piana F, Frisicale L, et al. Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB). New Microbiol 2004;27:221-227 (Pubitemid 40089472)
171. Matsiota-Bernard P, Vrioni G, Marinis E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol 1998;36:20-23 (Pubitemid 28047426)
172. McNerney R, Kiepiela P, Bishop KS, et al. Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin. Int J Tuberc Lung Dis 2000;4:69-75 (Pubitemid 30059287)
173. Goyal M, Shaw RJ, Banerjee DK, et al. Rapid detection of multidrug-resistant tuberculosis. Eur Respir J 1997;10:1120-1124 (Pubitemid 27201819)
174. Viader-Salvado JM, Luna-Aguirre CM, Reyes-Ruiz JM, et al. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico. Microb Drug Resist 2003;9:33-38 (Pubitemid 36403056)
175. Traore H, van Deun A, Shamputa IC, et al. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol 2006;44:4384-4388 (Pubitemid 44937068)
176. Quezada CM, Kamanzi E, Mukamutara J, et al. Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries. J Clin Microbiol 2007;45:3111-3114 (Pubitemid 47417369)
177. Alvarado-Esquivel C, Rossau R, Martinez-Garcia S, et al. Characterization of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients at 5 Mexican public hospitals. Rev Invest Clin 2001;53:526-530 (Pubitemid 34189684)
178. Sougakoff W, Rodrigue M, Truffot-Pernot C, et al. Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2004;10:289-294 (Pubitemid 38519354)
179. Shimizu Y, Dobashi K, Yoshikawa Y, et al. Five-antituberculosis Drug-resistance Genes Detection Using Array System. J Clin Biochem Nutr 2008;42:228-234 (Pubitemid 351913785)
180. Park H, Song EJ, Song ES, et al. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 2006;44:1619-1624 (Pubitemid 43726246)
181. Deng J, Zhang X, Lu H, et al. Multiplex detection of mutations in clinical isolates of rifampin-resistant Mycobacterium tuberculosis by short oligonucleotide ligation assay on DNA chips. J Clin Microbiol 2004;42:4850-4852 (Pubitemid 39362422)
182. Aragon LM, Navarro F, Heiser V, et al. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays. J Antimicrob Chemother 2006;57:825-831
183. Zhang S, Shen J, Xu P, et al. A novel genotypic test for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates by a multiplex probe array. J Appl Microbiol 2007;103:1262-1271 (Pubitemid 47493251)
184. Mikhailovich V, Lapa S, Gryadunov D, et al. Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and ligase detection reaction on oligonucleotide microchips. J Clin Microbiol 2001;39:2531-2540 (Pubitemid 32606229)
185. Kim S, Park Y, Song E, et al. Evaluation of the CombiChip Mycobacteria Drug-Resistance detection DNA chip for identifying mutations associated with resistance to isoniazid and rifampin in Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2006;54:203-210 (Pubitemid 43319368)
186. Gryadunov D, Mikhailovich V, Lapa S, et al. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin Microbiol Infect 2005;11:531-539 (Pubitemid 40895152)
187. Caoili JC, Mayorova A, Sikes D, et al. Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 2006;44:2378-2381 (Pubitemid 44092401)
188. Yue J, Shi W, Xie J, et al. Detection of rifampin-resistant Mycobacterium tuberculosis strains by using a specialized oligonucleotide microarray. Diagn Microbiol Infect Dis 2004;48:47-54 (Pubitemid 38167499)
189. Xu C, Zhou Y, Deng J, et al. On-chip ligation of multiplexing probe-pairs for identifying point mutations out of dense SNP loci. Biosens Bioelectron 2008 . Published online 15 Jul 2008, doi:10.1016/j.bios.2008.07.009
190. Gingeras TR, Ghandour G, Wang E, et al. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res 1998;8:435-448 (Pubitemid 28256794)
191. Head SR, Parikh K, Rogers YH, et al. Solid-phase sequence scanning for drug resistance detection in tuberculosis. Mol Cell Probes 1999;13:81-87 (Pubitemid 29206405)
192. Bockstahler LE, Li Z, Nguyen NY, et al. Peptide nucleic acid probe detection of mutations in Mycobacterium tuberculosis genes associated with drug resistance. Biotechniques 2002;32:508-10, 512, 514 (Pubitemid 34208067)
193. Edwards KJ, Metherell LA, Yates M, Saunders NA. Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J Clin Microbiol 2001;39:3350-3352 (Pubitemid 32830338)
194. Wada T, Maeda S, Tamaru A, et al. Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol 2004;42:5277-5285 (Pubitemid 39506241)
195. Espasa M, Gonzalez-Martin J, Alcaide F, et al. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. J Antimicrob Chemother 2005;55:860-865 (Pubitemid 40883168)
196. Varma-Basil M, El-Hajj H, Colangeli R, et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J Clin Microbiol 2004;42:5512-5516 (Pubitemid 39664329)
197. Piatek AS, Tyagi S, Pol AC, et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol 1998;16:359-363 (Pubitemid 28164656)
198. Piatek AS, Telenti A, Murray MR, et al. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother 2000;44:103-110 (Pubitemid 30010679)
199. El-Hajj HH, Marras SA, Tyagi S, et al. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol 2001;39:4131-4137 (Pubitemid 33029793)
200. Marin M, Garcia de Viedma D, Ruiz-Serrano MJ, Bouza E. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Antimicrob Agents Chemother 2004;48:4293-4300 (Pubitemid 39434889)
201. Kocagoz T, Saribas Z, Alp A. Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol 2005;43:6015-6019 (Pubitemid 43100653)
202. Sajduda A, Brzostek A, Poplawska M, et al. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol 2004;42:2425-2431 (Pubitemid 38747484)
203. Torres MJ, Criado A, Ruiz M, et al. Improved real-time PCR for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Diagn Microbiol Infect Dis 2003;45:207-212 (Pubitemid 36349662)
204. Garcia de Viedma D, del Sol Diaz Infantes M, Lasala F, et al. New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol 2002;40:988-995 (Pubitemid 34208657)
205. Krishnamurthy A, Rodrigues C, Mehta AP. Rapid detection of rifampicin resistance in m.tuberculosis by phage assay. Indian J Med Microbiol 2002;20:211-214
206. El-Sayed Zaki M, Goda T. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB. Tuberculosis (Edinb) 2007;87:102-108 (Pubitemid 46217258)
207. Albert H, Trollip AP, Linley K, et al. Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis. J Appl Microbiol 2007;103:892-899 (Pubitemid 47493242)
208. Albert H, Heydenrych A, Mole R, et al. Evaluation of FASTPlaqueTB-RIF, a rapid, manual test for the determination of rifampicin resistance from Mycobacterium tuberculosis cultures. Int J Tuberc Lung Dis 2001;5:906-911 (Pubitemid 32976634)
209. Kisa O, Albay A, Bedir O, et al. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis 2003;7:284-288 (Pubitemid 36358771)
210. Butt T, Ahmad RN, Afzal RK, et al. Rapid detection of rifampicin susceptibility of Mycobacterium tuberculosis in sputum specimens by mycobacteriophage assay. J Pak Med Assoc 2004;54:379-382 (Pubitemid 39208495)
211. Albert H, Trollip AP, Mole RJ, et al. Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF, a manual phage-based test. Int J Tuberc Lung Dis 2002;6:523-528 (Pubitemid 34601870)
212. da Silva PA, Boffo MMS, de Mattos IG, et al. Comparison of redox and D29 phage methods for detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2006;12:293-296
213. Yzquierdo SL, Lemus D, Echemendia M, et al. Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis. Ann Clin Microbiol Antimicrob 2006;5:11 (Pubitemid 43950603)
214. Simboli N, Takiff H, McNerney R, et al. In-house phage amplification assay is a sound alternative for detecting rifampin-resistant Mycobacterium tuberculosis in low-resource settings. Antimicrob Agents Chemother 2005;49:425-427
215. Gali N, Dominguez J, Blanco S, et al. Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates. J Clin Microbiol 2003;41:2647-2649 (Pubitemid 36712481)
216. Chauca JA, Palomino J, Guerra H. Evaluation of rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis by a mycobacteriophage D29-based assay. J Med Microbiol 2007;56:360-364 (Pubitemid 46363981)
217. Traore H, Ogwang S, Mallard K, et al. Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda. Ann Clin Microbiol Antimicrob 2007;6:1 (Pubitemid 46218601)
218. Eltringham IJ, Drobniewski FA, Mangan JA, et al. Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol 1999;37:3524-3527 (Pubitemid 29491086)
219. Riska PF, Su Y, Bardarov S, et al. Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol 1999;37:1144-1149 (Pubitemid 29140627)
220. Hazbon MH, Guarin N, Ferro BE, et al. Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2003;41:4865-4869 (Pubitemid 37259819)
221. Banaiee N, January V, Barthus C, et al. Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa. Tuberculosis (Edinb) 2008;88:64-68 (Pubitemid 350267360)
222. Banaiee N, Bobadilla-Del-Valle M, Riska PF, et al. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages. J Med Microbiol 2003;52:557-561 (Pubitemid 36871893)
223. Banaiee N, Bobadilla-Del-Valle M, Bardarov SJ, et al. Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico. J Clin Microbiol 2001;39:3883-3888 (Pubitemid 33029755)
224. Jacobs WRJ, Barletta RG, Udani R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993;260:819-822 (Pubitemid 23167613)
225. McNerney R, Mallard K, Urassa HMR, et al. Colorimetric phage-based assay for detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007;45:1330-1332 (Pubitemid 46626509)
226. Reis RS, Neves IJ, Lourenco SLS, et al. Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid. J Clin Microbiol 2004;42:2247-2248 (Pubitemid 38637855)
227. Palomino JC, Portaels F. Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetic assay. Eur J Clin Microbiol Infect Dis 1999;18:380-383 (Pubitemid 29531179)
228. Luna-Herrera J, Martinez-Cabrera G, Parra-Maldonado R, et al. Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 2003;22:21-27 (Pubitemid 36286689)
229. Franzblau SG, Witzig RS, Mclaughlin JC, et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 1998;36:362-366 (Pubitemid 28060296)
230. Chauca J, Palomino J, Guerra H. Evaluation of the accuracy of the microplate Alamar Blue assay for rapid detection of MDR-TB in Peru. Int J Tuberc Lung Dis 2007;11:820-822 (Pubitemid 47056995)
231. Moore DAJ, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004;42:4432-4437 (Pubitemid 39362351)
232. Mengatto L, Chiani Y, Imaz MS. Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 2006;101:535-542 (Pubitemid 44285796)
233. Martin A, Morcillo N, Lemus D, et al. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis 2005;9:901-906 (Pubitemid 41139650)
234. Foongladda S, Roengsanthia D, Arjrattanakool W, et al. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2002;6:1118-1122 (Pubitemid 36054968)
235. Abate G, Mshana RN, Miorner H. Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1998;2:1011-1016
236. Caviedes L, Delgado J, Gilman RH. Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 2002;40:1873-1874 (Pubitemid 34493180)
237. Mshana RN, Tadesse G, Abate G, Miorner H. Use of 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyl tetrazolium bromide for rapid detection of rifampin-resistant Mycobacterium tuberculosis. J Clin Microbiol 1998;36:1214-1219
238. De Logu A, Uda P, Pellerano ML, et al. Comparison of two rapid colorimetric methods for determining resistance of mycobacterium tuberculosis to rifampin, isoniazid, and streptomycin in liquid medium. Eur J Clin Microbiol Infect Dis 2001;20:33-39 (Pubitemid 32200359)
239. Rivoire N, Ravololonandriana P, Rasolonavalona T, et al. Evaluation of the resazurin assay for the detection of multidrug-resistant Mycobacterium tuberculosis in Madagascar. Int J Tuberc Lung Dis 2007;11:683-688 (Pubitemid 46868631)
240. Palomino J, Martin A, Camacho M, et al. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002;46:2720-2722 (Pubitemid 34793497)
241. Nateche F, Martin A, Baraka S, et al. Application of the resazurin microtitre assay for detection of multidrug resistance in Mycobacterium tuberculosis in Algiers. J Med Microbiol 2006;55:857-860 (Pubitemid 43974690)
242. Banfi E, Scialino G, Monti-Bragadin C. Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility. J Antimicrob Chemother 2003;52:796-800 (Pubitemid 37407807)
243. Affolabi D, Sanoussi N, Odoun M, et al. Rapid detection of multidrug-resistant Mycobacterium tuberculosis in Cotonou (Benin) using two low-cost colorimetric methods: resazurin and nitrate reductase assays. J Med Microbiol 2008;57:1024-1027
244. Honscha G, Von Groll A, Valenca M, et al. The laboratory as a tool to qualify tuberculosis diagnosis. Int J Tuberc Lung Dis 2008;12:218-220 (Pubitemid 351212416)
245. De Logu A, Pellerano ML, Sanna A, et al. Comparison of the susceptibility testing of clinical isolates of Mycobacterium tuberculosis by the XTT colorimetric method and the NCCLS standards method. Int J Antimicrob Agents 2003;21:244-250 (Pubitemid 36299186)
246. De Logu A, Borgna R, Uda P, et al. The 2,3-bis(2-methoxy-4-nitro-5- sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay as rapid colorimetric method for determination of antibiotic susceptibility of clinical Mycobacterium tuberculosis isolates in liquid medium. Clin Lab 2003;49:357-365 (Pubitemid 36975254)
247. Lee S, Kong DH, Yun SH, et al. Evaluation of a modified antimycobacterial susceptibility test using Middlebrook 7H10 agar containing 2,3-diphenyl-5- thienyl-(2)-tetrazolium chloride. J Microbiol Methods 2006;66:548-551 (Pubitemid 44062003)
248. Mohammadzadeh A, Farnia P, Ghazvini K, et al. Rapid and low-cost colorimetric method using 2,3,5-triphenyltetrazolium chloride for detection of multidrug-resistant Mycobacterium tuberculosis. J Med Microbiol 2006;55:1657-1659
249. Asencios L, Yale G, Yagui M, et al. Programmatic implementation of rapid DST for Mycobacterium tuberculosisin Peru. Int J Tuberc Lung Dis 2008;12:743-749 (Pubitemid 351976703)
250. Sethi S, Sharma S, Sharma SK, et al. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay. Indian J Med Res 2004;120:468-471 (Pubitemid 40044917)
251. Martin A, Montoro E, Lemus D, et al. Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis. J Microbiol Methods 2005;63:145-150 (Pubitemid 41443323)
252. Lemus D, Montoro E, Echemendia M, et al. Nitrate reductase assay for detection of drug resistance in Mycobacterium tuberculosis: simple and inexpensive method for low-resource laboratories. J Med Microbiol 2006;55:861-863 (Pubitemid 43974691)
253. Coban AY, Birinci A, Ekinci B, et al. Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay. Int J Antimicrob Agents 2004;24:304-306 (Pubitemid 39140553)
254. Angeby KAK, Klintz L, Hoffner SE. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 2002;40:553-555 (Pubitemid 34130881)
255. Syre H, Phyu S, Sandven P, et al. Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J Clin Microbiol 2003;41:5173-5177 (Pubitemid 37429932)
256. Shiferaw G, Woldeamanuel Y, Gebeyehu M, et al. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007;45:1093-1097 (Pubitemid 46626469)
257. Mello FCQ, Arias MS, Rosales S, et al. Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol 2007;45:3387-3389 (Pubitemid 47585667)
258. Ejigu GS, Woldeamanuel Y, Shah NS, et al. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis 2008;12:332-337 (Pubitemid 351361906)